Skip to main content
Article
Abstract P6-10-09: Multispectral immunofluorescence (mIF) to detect dynamic changes in PD-L1 expression, immune cell (IC) infiltration, and tumor-IC interactions in primary breast cancer (BC) immuno-oncology (I-O) clinical trials
Cancer Research (2020)
  • Katherine Sanchez, Earle A. Chiles Research Institute, Portland, OR;
  • Isaac Kim, Earle A. Chiles Research Institute, Portland, OR;
  • ShuChing Chang, Earle A. Chiles Research Institute, Portland, OR;
  • Maritza Martel, Earle A. Chiles Research Institute, Portland, OR;
  • Yaping Wu, Earle A. Chiles Research Institute, Portland, OR;
  • Brady Bernard, Earle A. Chiles Research Institute, Portland, OR;
  • Joanna Pucilowska, Earle A. Chiles Research Institute, Portland, OR;
  • Zhaoyu Sun, Earle A. Chiles Research Institute, Portland, OR;
  • William Redmond, Earle A. Chiles Research Institute, Portland, OR;
  • Dottie Waddell, Patient Advocate, Portland, OR
  • Walter Urba, Earle A. Chiles Research Institute, Portland, OR;
  • David B Page, Earle A. Chiles Research Institute, Portland, OR;
Publication Date
February 15, 2020
DOI
10.1158/1538-7445.SABCS19-P6-10-09
Citation Information
Katherine Sanchez, Isaac Kim, ShuChing Chang, Maritza Martel, et al.. "Abstract P6-10-09: Multispectral immunofluorescence (mIF) to detect dynamic changes in PD-L1 expression, immune cell (IC) infiltration, and tumor-IC interactions in primary breast cancer (BC) immuno-oncology (I-O) clinical trials" Cancer Research Vol. 80 (2020)
Available at: http://works.bepress.com/walter-urba/288/